Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1075-2024Class II

Microbiologics Enteric Pathogens Control Panel (Inactivated Pellet), REF 8184

Microbiologics, Inc. / initiated 2024-01-08 / Open, Classified / root cause: manufacturing process

Microbiologics Inc began a recall of Microbiologics Enteric Pathogens Control Panel (Inactivated Pellet), REF 8184 on . FDA classified it as Class II and gives the reason as "The negative control was contaminated with one of the positive control pathogens (Norovirus). This would result in users getting a positive call for Norovirus when running the negative control". As of , the recall status on record is Open, Classified, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-1075-2024
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Microbiologics, Inc.
Product
Microbiologics Enteric Pathogens Control Panel (Inactivated Pellet), REF 8184.
Product code
OHQ Multi-Analyte Controls Unassayed
Reason for recall
The negative control was contaminated with one of the positive control pathogens (Norovirus). This would result in users getting a positive call for Norovirus when running the negative control.
Root cause tag
manufacturing process
FDA root cause
Process control
Action
The recalling firm issued letters dated 1/8/2024 beginning 1/8/2024 informing the consignee of the issue and providing the following instructions: (1) Review lab procedures to understand how this information affects your usage; (2) Use or discard depending on your lab procedures and how this information affects your usage; (3) Complete the response form provided; (4) Return the response form to the firm; (5) keep the letter for your records; and (6) contact Microbiologics if a replacement kit is needed. On 1/25/2024, the firm issued letters dated 1/24/2024 via email to notify consignees they have expanded the recall to include additional lot numbers. Other than providing additional lot numbers, the letter was the same as the initial letter issued on 1/8/2024. The firm reported the email that had the letter attached alerted the consignee that the recall was expanded to include additional lot numbers.
Quantity in commerce
580 packages
Distribution
US Nationwide distribution in the states of AL, AZ, CA, CO, CT, DE, FL, GA, IA, ID, IL, IN, KS, KY, MA, MI, MN, MO, MS, MT, NE, NH, NJ, NY, OH, PA, RI, TN, TX, VA, WA, WI, WV, and WY. There was government distribution and no military distribution. Foreign distribution was made to France.
Product codes and lots
Lot #8184-68, Exp. 5/31/2025, UDI-DI 70845357041448. UPDATE: The recall was expanded on 1/23/2024 to include the following additional lot numbers: 8184-65, exp. 3/31/2025; 8184-66, exp. 4/30/2025; 8184-67, exp. 5/31/2025; 8184-69, exp. 6/30/2025; 8184-70, exp. 8/31/2025; and 8184-71, exp. 8/31/2025.

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1075-2024
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1075-2024Class IIOngoingVoluntary: Firm initiated